Systemic lupus erythematosus, regulatory T cells and pregnancy

References

• D’cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet369(9561), 587–596 (2007).
   PubMed Web of Science ®Google Scholar
• Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus15(5), 308–318 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson-Piercy C. Handbook of Obstetric Medicine (Third Edition). Informa Healthcare, London, UK, 140–145 (2006).
   Google Scholar
• Madazli R, Bulut B, Erenel H, Gezer A, Guralp O. Systemic lupus erythematosus and pregnancy. J. Obstet. Gynaecol.30(1), 17–20 (2010).
   PubMedGoogle Scholar
• Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin. J. Am. Soc. Nephrol.5(11), 2060–2068 (2010).
   PubMed Web of Science ®Google Scholar
• Dorling J. Centre for Maternal and Child Enquiries (CMACE) Perinatal Mortality 2008: United Kingdom. CMACE, London, UK (2010).
   Google Scholar
• Kontaki E, Boumpas DT. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids. J. Autoimmun.35(3), 206–211 (2010).
   PubMed Web of Science ®Google Scholar
• Veenstra Van Nieuwenhoven AL, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum. Reprod. Update9(4), 347–357 (2003).
   PubMed Web of Science ®Google Scholar
• Ohkura N, Sakaguchi S. Regulatory T cells: roles of T cell receptor for their development and function. Semin. Immunopathol.32(2), 95–106 (2010).
   PubMed Web of Science ®Google Scholar
• Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum.42(6), 1219–1227 (1999).
   PubMed Web of Science ®Google Scholar
• Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG118(7), 790–797 (2011).
   PubMed Web of Science ®Google Scholar
• Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. 7, 320–338 (1953).
   Google Scholar
• Chaouat G, Kolb JP, Wegmann TG. The murine placenta as an immunological barrier between the mother and the fetus. Immunol. Rev.75, 31–60 (1983).
   PubMed Web of Science ®Google Scholar
• Luppi P. How immune mechanisms are affected by pregnancy. Vaccine21(24), 3352–3357 (2003).
   PubMed Web of Science ®Google Scholar
• Lyall F. The human placental bed revisited. Placenta23(8–9), 555–562 (2002).
   PubMed Web of Science ®Google Scholar
• Yoshinaga K. Research on blastocyst implantation essential factors (BIEFs). Am. J. Reprod. Immunol.63(6), 413–424 (2010).
   PubMed Web of Science ®Google Scholar
• Dimitriadis E, Nie G, Hannan NJ, Paiva P, Salamonsen LA. Local regulation of implantation at the human fetal–maternal interface. Int. J. Dev. Biol.54(2–3), 313–322 (2010).
   PubMed Web of Science ®Google Scholar
• Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol.2(9), 656–663 (2002).
   PubMed Web of Science ®Google Scholar
• Abrahams VM, Kim YM, Straszewski SL, Romero R, Mor G. Macrophages and apoptotic cell clearance during pregnancy. Am. J. Reprod. Immunol.51(4), 275–282 (2004).
   PubMed Web of Science ®Google Scholar
• Tabiasco J, Rabot M, Aguerre-Girr M et al. Human decidual NK cells: unique phenotype and functional properties – a review. Placenta27(Suppl. A), S34–S39 (2006).
   Google Scholar
• Cartwright JE, Fraser R, Leslie K, Wallace AE, James JL. Remodelling at the maternal–fetal interface: relevance to human pregnancy disorders. Reproduction140(6), 803–813 (2010).
   PubMed Web of Science ®Google Scholar
• Nagamatsu T, Schust DJ. The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol.63(6), 460–471 (2010).
   PubMed Web of Science ®Google Scholar
• Mizuno M, Aoki K, Kimbara T. Functions of macrophages in human decidual tissue in early pregnancy. Am. J. Reprod. Immunol.31(4), 180–188 (1994).
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O. Phenotypic characterization of human decidual macrophages. Clin. Exp. Immunol.131(3), 498–505 (2003).
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol.136(2), 373–378 (2004).
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science281(5380), 1191–1193 (1998).
   PubMed Web of Science ®Google Scholar
• Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am. J. Pathol.174(5), 1959–1971 (2009).
   PubMed Web of Science ®Google Scholar
• Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens63(1), 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol.30(6), 1538–1543 (2000).
   PubMed Web of Science ®Google Scholar
• Walker MR, Kasprowicz DJ, Gersuk VH et al. Induction of FOXP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest.112(9), 1437–1443 (2003).
   PubMed Web of Science ®Google Scholar
• Stephens LA, Mottet C, Mason D, Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.Eur. J. Immunol.31(4), 1247–1254 (2001).
   PubMed Web of Science ®Google Scholar
• Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.J. Immunol.166(6), 3789–3796 (2001).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. FOXP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4(4), 330–336 (2003).
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science299(5609), 1057–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.4(4), 337–342 (2003).
   PubMed Web of Science ®Google Scholar
• Roncador G, Brown PJ, Maestre L et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol.35(6), 1681–1691 (2005).
   PubMed Web of Science ®Google Scholar
• Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr.100(5), 731–737 (1982).
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med.203(7), 1693–1700 (2006).
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FOXP3 and suppressive function of human CD4+ Treg cells. J. Exp. Med.203(7), 1701–1711 (2006).
   PubMed Web of Science ®Google Scholar
• Hartigan-O’Connor DJ, Poon C, Sinclair E, Mccune JM. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor α chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods319(1–2), 41–52 (2007).
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Tangye SG et al. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood107(7), 2830–2838 (2006).
   PubMed Web of Science ®Google Scholar
• Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest.115(7), 1953–1962 (2005).
   PubMed Web of Science ®Google Scholar
• Fritzsching B, Oberle N, Pauly E et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood108(10), 3371–3378 (2006).
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat. Rev. Immunol.8(7), 523–532 (2008).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol.10(7), 490–500 (2010).
   PubMed Web of Science ®Google Scholar
• Miyara M, Yoshioka Y, Kitoh A et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FOXP3 transcription factor. Immunity30(6), 899–911 (2009).
   PubMed Web of Science ®Google Scholar
• Ito M, Nakashima A, Hidaka T et al. A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour. J. Reprod. Immunol.84(1), 75–85 (2010).
   PubMed Web of Science ®Google Scholar
• Mjosberg J, Berg G, Jenmalm MC, Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol. Reprod.82(4), 698–705 (2010).
   PubMed Web of Science ®Google Scholar
• Tilburgs T, Roelen DL, Van Der Mast BJ et al. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta27(Suppl. A), S47–S53 (2006).
   PubMed Web of Science ®Google Scholar
• Mold JE, Michaelsson J, Burt TD et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science322(5907), 1562–1565 (2008).
   PubMed Web of Science ®Google Scholar
• Takahata Y, Nomura A, Takada H et al. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (FOXP3) gene. Exp. Hematol.32(7), 622–629 (2004).
   PubMed Web of Science ®Google Scholar
• Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol.5(3), 266–271 (2004).
   PubMed Web of Science ®Google Scholar
• Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol.178(4), 2572–2578 (2007).
   PubMed Web of Science ®Google Scholar
• Robertson SA, Guerin LR, Moldenhauer LM, Hayball JD. Activating T regulatory cells for tolerance in early pregnancy – the contribution of seminal fluid. J. Reprod. Immunol.83(1–2), 109–116 (2009).
   PubMed Web of Science ®Google Scholar
• Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update15(5), 517–535 (2009).
   PubMed Web of Science ®Google Scholar
• Schumacher A, Brachwitz N, Sohr S et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal–maternal interface during early human pregnancy. J. Immunol.182(9), 5488–5497 (2009).
   PubMed Web of Science ®Google Scholar
• Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today14(7), 353–356 (1993).
   PubMedGoogle Scholar
• Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today18(10), 478–482 (1997).
   PubMedGoogle Scholar
• Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Inflammation and pregnancy. Reprod. Sci.16(2), 206–215 (2009).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Th1/Th2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the Th1/Th2 paradigm. Int. Arch. Allergy. Immunol.134(2), 93–119 (2004).
   PubMed Web of Science ®Google Scholar
• Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum. Reprod.17(9), 2439–2444 (2002).
   PubMed Web of Science ®Google Scholar
• Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology112(1), 38–43 (2004).
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod.10(5), 347–353 (2004).
   PubMed Web of Science ®Google Scholar
• Chirico DEA. Predictors of pregnancy complications in women with systemic lupus erythematosus. BJOG116, 1407–1408 (2009).
   Google Scholar
• Xiong H, Zhou C, Qi G. Proportional changes of CD4+CD25+FOXP3+ regulatory T cells in maternal peripheral blood during pregnancy and labor at term and preterm. Clin. Invest. Med.33(6), E422 (2010).
   Web of Science ®Google Scholar
• Mjosberg J, Svensson J, Johansson E et al. Systemic reduction of functionally suppressive CD4dimCD25highFOXP3+ Tregs in human second trimester pregnancy is induced by progesterone and 17β-estradiol. J. Immunol.183(1), 759–769 (2009).
   PubMed Web of Science ®Google Scholar
• Leber A, Teles A, Zenclussen AC. Regulatory T cells and their role in pregnancy. Am. J. Reprod. Immunol.63(6), 445–459 (2010).
   PubMed Web of Science ®Google Scholar
• Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin. Exp. Immunol.159(2), 109–119 (2010).
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol.63(6), 601–610 (2010).
   PubMed Web of Science ®Google Scholar
• Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat. Rev. Immunol.7(3), 231–237 (2007).
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor FOXP3. J. Exp. Med.198(12), 1875–1886 (2003).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature441(7090), 235–238 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma MD, Hou DY, Liu Y et al. Indoleamine 2,3-dioxygenase controls conversion of FOXP3+ Tregs to Th17-like cells in tumor-draining lymph nodes. Blood113(24), 6102–6111 (2009).
   PubMed Web of Science ®Google Scholar
• Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S. Circulating and decidual Th17 cell levels in healthy pregnancy. Am. J. Reprod. Immunol.63(2), 104–109 (2010).
   PubMed Web of Science ®Google Scholar
• Santner-Nanan B, Peek MJ, Khanam R et al. Systemic increase in the ratio between FOXP3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol.183(11), 7023–7030 (2009).
   PubMed Web of Science ®Google Scholar
• Crispin JC, Kyttaris V, Juang YT, Tsokos GC. Systemic lupus erythematosus: new molecular targets. Ann. Rheum. Dis.66(Suppl. 3), iii65–iii69 (2007).
   PubMedGoogle Scholar
• Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-ds DNA antibodies: are we approaching journey’s end? Rheumatology (Oxford)46(7), 1052–1056 (2007).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med.161(1), 72–87 (1985).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann. Rev. Immunol.22, 531–562 (2004).
   PubMed Web of Science ®Google Scholar
• Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med.184(2), 387–396 (1996).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Hasegawa K, Adachi C. Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice. Int. J. Exp. Pathol.86(5), 289–296 (2005).
   PubMed Web of Science ®Google Scholar
• Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol.177(3), 1451–1459 (2006).
   PubMed Web of Science ®Google Scholar
• Hsu WT, Suen JL, Chiang BL. The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin. Exp. Immunol.145(3), 513–519 (2006).
   PubMed Web of Science ®Google Scholar
• Monk CR, Spachidou M, Rovis F et al. MRL/Mp CD4+, CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum.52(4), 1180–1184 (2005).
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet.27(1), 68–73 (2001).
   PubMed Web of Science ®Google Scholar
• Riemekasten G, Langnickel D, Enghard P et al. Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J. Immunol.173(9), 5835–5842 (2004).
   PubMed Web of Science ®Google Scholar
• Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J. Immunol.178(12), 7849–7858 (2007).
   PubMed Web of Science ®Google Scholar
• Horwitz DA. Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res. Ther.10(6), 227 (2008).
   PubMedGoogle Scholar
• Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus16(7), 489–496 (2007).
   PubMed Web of Science ®Google Scholar
• Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun.21(3), 273–276 (2003).
   PubMed Web of Science ®Google Scholar
• Barath S, Soltesz P, Kiss E et al. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FOXP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity40(7), 521–528 (2007).
   PubMed Web of Science ®Google Scholar
• Miyara M, Amoura Z, Parizot C et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol.175(12), 8392–8400 (2005).
   PubMed Web of Science ®Google Scholar
• Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol.178(4), 2579–2588 (2007).
   PubMed Web of Science ®Google Scholar
• Bonelli M, Savitskaya A, Von Dalwigk K et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol.20(7), 861–868 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE. Clinical significance of increased CD4+CD25-FOXP3+ T cells in patients with new-onset systemic lupus erythematosus. Ann. Rheum. Dis.67(7), 1037–1040 (2008).
   PubMed Web of Science ®Google Scholar
• Venigalla RK, Tretter T, Krienke S et al. Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum.58(7), 2120–2130 (2008).
   PubMed Web of Science ®Google Scholar
• Franz B, Fritzsching B, Riehl A et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum.56(6), 1910–1920 (2007).
   PubMed Web of Science ®Google Scholar
• Yates J, Whittington A, Mitchell P, Lechler RI, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin. Exp. Immunol.153(1), 44–55 (2008).
   PubMed Web of Science ®Google Scholar
• Mesquita D, de Melo Cruvinel W, Araujo J et al. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells. Scand. J. Rheumatol.40(1), 41–50 (2011).
   PubMed Web of Science ®Google Scholar
• Klein S, Kretz CC, Krammer PH, Kuhn A. CD127(low/-) and FOXP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. J. Invest. Dermatol.130(2), 492–499 (2010).
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Increased expression of the FOXP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin. Immunol.123(1), 66–73 (2007).
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med.188(2), 287–296 (1998).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kuniyasu Y, Toda M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol.10(12), 1969–1980 (1998).
   PubMed Web of Science ®Google Scholar
• Oberle N, Eberhardt N, Falk CS, Krammer PH, Suri-Payer E. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+FOXP3+ regulatory T cells: independence of IL-2 consumption, TGF-β, and various inhibitors of TCR signaling. J. Immunol.179(6), 3578–3587 (2007).
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity21(4), 589–601 (2004).
   PubMed Web of Science ®Google Scholar
• Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood109(5), 2058–2065 (2007).
   PubMed Web of Science ®Google Scholar
• Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity30(5), 636–645 (2009).
   PubMed Web of Science ®Google Scholar
• Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. FOXP3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. USA105(29), 10113–10118 (2008).
   PubMed Web of Science ®Google Scholar
• DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM. Autoantigen-specific TGFβ-induced FOXP3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol.179(7), 4685–4693 (2007).
   PubMed Web of Science ®Google Scholar
• Xing Q, Wang B, Su H, Cui J, Li J. Elevated Th17 cells are accompanied by FOXP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol. Int. DOI: 10.1007/s00296-010-1771-0 (2011) (Epub ahead of print).
   Google Scholar
• Ma J, Yu J, Tao X, Cai L, Wang J, Zheng SG. The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin. Rheumatol.29(11), 1251–1258 (2010).
   PubMed Web of Science ®Google Scholar
• Becker-Merok A, Eilertsen GO, Nossent JC. Levels of transforming growth factor-β are low in systemic lupus erythematosus patients with active disease. J. Rheumatol.37(10), 2039–2045 (2010).
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Raveendran A, Suri V, Chopra S, Sikka P, Sharma A. Pregnancy outcome in systemic lupus erythematosus: Asia’s largest single centre study. Arch. Gynecol. Obstet.284(2), 281–285 (2010).
   PubMed Web of Science ®Google Scholar
• Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol.199(2), 127 e121–e126 (2008).
   Google Scholar
• Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol. Int.50(3), 224–229 (2000).
   PubMed Web of Science ®Google Scholar
• Costa AM, Maximiano EB, Avvad-Portari E, Jesus NR, Levy RA, Porto LC. Contractile cells and fibrillin-1 distribution is disturbed in terminal villi of placentae from patients with preeclampsia and systemic lupus erythematosus. Placenta27(2–3), 234–243 (2006).
   PubMed Web of Science ®Google Scholar
• Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature. Hum. Pathol.27(2), 201–206 (1996).
   PubMed Web of Science ®Google Scholar
• Ornoy A, Chen L, Silver RM, Miller RK. Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. Birth Defects Res. A. Clin. Mol. Teratol.70(6), 371–381 (2004).
   PubMedGoogle Scholar
• Ornoy A, Yacobi S, Matalon ST et al. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus12(7), 573–578 (2003).
   PubMed Web of Science ®Google Scholar
• Schwartz N, Shoenfeld Y, Barzilai O et al. Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS. Lupus16(2), 110–120 (2007).
   PubMed Web of Science ®Google Scholar
• Clowse ME. Lupus activity in pregnancy. Rheum. Dis. Clin. North Am.33(2), 237–252, v (2007).
   PubMed Web of Science ®Google Scholar
• Gupta R, Deepanjali S, Kumar A et al. A comparative study of pregnancy outcomes and menstrual irregularities in northern Indian patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol. Int.30(12), 1581–1585 (2010).
   PubMed Web of Science ®Google Scholar
• Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum.52(2), 514–521 (2005).
   PubMed Web of Science ®Google Scholar
• Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH, Lin QD. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum. Reprod.25(10), 2591–2596 (2010).
   PubMed Web of Science ®Google Scholar
• Arruvito L, Sotelo AI, Billordo A, Fainboim L. A physiological role for inducible FOXP3(+) Treg cells. Lessons from women with reproductive failure. Clin. Immunol.136(3), 432–441 (2010).
   PubMed Web of Science ®Google Scholar
• Liu YS, Wu L, Tong XH et al. Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am. J. Reprod. Immunol.65(5), 503–511 (2010).
   PubMed Web of Science ®Google Scholar
• Yang H, Qiu L, Chen G, Ye Z, Lu C, Lin Q. Proportional change of CD4+CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil. Steril.89(3), 656–661 (2008).
   PubMed Web of Science ®Google Scholar
• Wang WJ, Hao CF, Yi L et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J. Reprod. Immunol.84(2), 164–170 (2010).
   PubMed Web of Science ®Google Scholar
• Shima T, Sasaki Y, Itoh M et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J. Reprod. Immunol.85(2), 121–129 (2010).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol.166(3), 811–822 (2005).
   PubMed Web of Science ®Google Scholar
• Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North. Am.23(1), 1–13 (1997).
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Colon I, Langen ES et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol.192(6), 1897–1904 (2005).
   PubMed Web of Science ®Google Scholar
• Crocker I. Gabor Than Award Lecture 2006: pre-eclampsia and villous trophoblast turnover: perspectives and possibilities. Placenta28(Suppl. A), S4–S13 (2007).
   PubMedGoogle Scholar
• Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol. Asp. Med.28(2), 192–209 (2007).
   PubMed Web of Science ®Google Scholar
• Hu D, Chen Y, Zhang W, Wang H, Wang Z, Dong M. Alteration of peripheral CD4+CD25+ regulatory T lymphocytes in pregnancy and pre-eclampsia. Acta. Obstet. Gynecol. Scand.87(2), 190–194 (2008).
   PubMed Web of Science ®Google Scholar
• Paeschke S, Chen F, Horn N et al. Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am. J. Reprod. Immunol.54(6), 384–389 (2005).
   PubMed Web of Science ®Google Scholar
• Steinborn A, Haensch GM, Mahnke K et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin. Immunol.129(3), 401–412 (2008).
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Darmochwal-Kolarz D, Suzuki D et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin. Exp. Immunol.149(1), 139–145 (2007).
   PubMed Web of Science ®Google Scholar
• Toldi G, Rigo J Jr, Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol.66(3), 223–229 (2011).
   PubMed Web of Science ®Google Scholar
• Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia – a step forward but not the definitive answer. J. Reprod. Immunol.82(2), 106–111 (2009).
   PubMed Web of Science ®Google Scholar
• Lamarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr. Hypertens. Rep.9(6), 480–485 (2007).
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest.111(5), 649–658 (2003).
   PubMed Web of Science ®Google Scholar
• Qazi U, Lam C, Karumanchi SA, Petri M. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J. Rheumatol.35(4), 631–634 (2008).
   PubMed Web of Science ®Google Scholar
• Motomura Y, Kanbayashi H, Khan WI et al. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-β type II receptor gene transfer. Am. J. Phys.288(1), G143–150 (2005).
   Google Scholar
• Salmon JE, Heuser C, Triebwasser M et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med.8(3), e1001013 (2011).
   PubMed Web of Science ®Google Scholar
• Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med.203(9), 2165–2175 (2006).
   PubMed Web of Science ®Google Scholar
• Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M. Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis. Ann. Rheum. Dis.67(7), 984–990 (2008).
   PubMed Web of Science ®Google Scholar
• Forger F, Villiger PM, Ostensen M. Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role? Arthritis Rheum.61(2), 279–283 (2009).
   PubMed Web of Science ®Google Scholar
• Allan SE, Broady R, Gregori S et al. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol. Rev.223, 391–421 (2008).
   PubMed Web of Science ®Google Scholar
• Gao W, Lu Y, El Essawy B, Oukka M, Kuchroo VK, Strom TB. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am. J. Transplant7(7), 1722–1732 (2007).
   PubMed Web of Science ®Google Scholar
• Jee Y, Piao WH, Liu R et al. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin. Immunol.125(1), 34–42 (2007).
   PubMed Web of Science ®Google Scholar
• Tao R, De Zoeten EF, Ozkaynak E et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med.13(11), 1299–1307 (2007).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC. CD4(+)CD25+ T regulatory cells in murine pregnancy. J. Reprod. Immunol.65(2), 101–110 (2005).
   PubMed Web of Science ®Google Scholar
• Clark DA, Fernandes J, Banwatt D. Prevention of spontaneous abortion in the CBA x DBA/2 mouse model by intravaginal TGF-β and local recruitment of CD4+8+ FOXP3+ cells. Am. J. Reprod. Immunol.59(6), 525–534 (2008).
   PubMed Web of Science ®Google Scholar
• Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum. Reprod.24(11), 2703–2708 (2009).
   PubMed Web of Science ®Google Scholar
• Kato Y, Kuwabara T, Itoh T et al. A possible relationship between abortions and placental embolism in pregnant rabbits given human granulocyte colony-stimulating factor. J. Toxicol. Sci.26(1), 39–50 (2001).
   PubMedGoogle Scholar
• Suntharalingam G, Perry MR, Ward S et al. Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med.355(10), 1018–1028 (2006).
   PubMed Web of Science ®Google Scholar